Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed that, the management and officials of the Company will be meeting in person with various investors on December 05, 2023 at Singapore. No Unpublished Price Sensitive Information will be shared at the aforesaid investor meetings.
The above information is a part of company’s filings submitted to BSE.